Henry Patton Doggrell, VP, Chief Legal Officer at Oncternal Therapeutics, holds 48.17K shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Henry Patton Doggrell Sold $7,351 shares of Oncternal Therapeutics on Jun 22, 2018 for an estimated value of 139.67K.